A Randomized Phase II Trial of Multi-epitope Vaccination with Melanoma Peptides for Cytotoxic T-Cells and Helper T-Cells for Patients with Metastatic Melanoma (E1602)

Por Slingluff, Craig L., Lee, Sandra, Zhao, Fengmin, Chianese-Bullock, Kimberly A., Olson, Walter, Butterfield, Lisa H., Whiteside, Theresa, Leming, Philip D., Kirkwood, John M.
Publicado em 2013

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

Por Topalian, Suzanne L., Sznol, Mario, McDermott, David F., Kluger, Harriet M., Carvajal, Richard D., Sharfman, William H., Brahmer, Julie R., Lawrence, Donald P., Atkins, Michael B., Powderly, John D., Leming, Philip D., Lipson, Evan J., Puzanov, Igor, Smith, David C., Taube, Janis M., Wigginton, Jon M., Kollia, Georgia D., Gupta, Ashok, Pardoll, Drew M., Sosman, Jeffrey A., Hodi, F. Stephen
Publicado no J Clin Oncol (2014)

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Por Topalian, Suzanne L., Hodi, F. Stephen, Brahmer, Julie R., Gettinger, Scott N., Smith, David C., McDermott, David F., Powderly, John D., Carvajal, Richard D., Sosman, Jeffrey A., Atkins, Michael B., Leming, Philip D., Spigel, David R., Antonia, Scott J., Horn, Leora, Drake, Charles G., Pardoll, Drew M., Chen, Lieping, Sharfman, William H., Anders, Robert A., Taube, Janis M., McMiller, Tracee L., Xu, Haiying, Korman, Alan J., Jure-Kunkel, Maria, Agrawal, Shruti, McDonald, Daniel, Kollia, Georgia D., Gupta, Ashok, Wigginton, Jon M., Sznol, Mario
Publicado em 2012